143 related articles for article (PubMed ID: 17703446)
41. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
42. A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol.
Kitchener HC; Gittins M; Desai M; Smith JH; Cook G; Roberts C; Turnbull L
Health Technol Assess; 2015 Mar; 19(22):i-xix, 1-64. PubMed ID: 25774649
[TBL] [Abstract][Full Text] [Related]
43. Comparison of conventional Papanicolaou smears and fluid-based, thin-layer cytology with colposcopic biopsy control in central Italy: a consecutive sampling study of 461 cases.
Rahimi S; Carnovale-Scalzo C; Marani C; Renzi C; Malvasi A; Votano S
Diagn Cytopathol; 2009 Jan; 37(1):1-3. PubMed ID: 18973131
[TBL] [Abstract][Full Text] [Related]
44. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
45. Using a quality control approach to define an 'adequately cellular' liquid-based cervical cytology specimen.
McQueen F; Duvall E
Cytopathology; 2006 Aug; 17(4):168-74. PubMed ID: 16879263
[TBL] [Abstract][Full Text] [Related]
46. [Acceptable quality cervical cytology taking: comparison of Cervex-brush and Cervex-mex methods].
Ojeda Ortiz J; Muñoz Molina R; Pardo López M; Guevara Cruz M; Hernández Quijano T; Valencia Elizondo C; Hernández Valencia M
Ginecol Obstet Mex; 2008 Jul; 76(7):381-5. PubMed ID: 18798438
[TBL] [Abstract][Full Text] [Related]
47. Intralaboratory reproducibility in cervical cytology. Results of the application of a 100-slide set.
Confortini M; Biggeri A; Cariaggi MP; Carozzi FM; Minuti PA; Russo A; Palli D
Acta Cytol; 1993; 37(1):49-54. PubMed ID: 8434496
[TBL] [Abstract][Full Text] [Related]
48. Cell block as an adjunct to conventional Papanicolaou smear for diagnosis of cervical cancer in resource-limited settings.
Gupta S; Halder K; Khan VA; Sodhani P
Cytopathology; 2007 Oct; 18(5):309-15. PubMed ID: 17681012
[TBL] [Abstract][Full Text] [Related]
49. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears?
Clelland CA
Cytopathology; 2002 Apr; 13(2):134-5. PubMed ID: 11952755
[No Abstract] [Full Text] [Related]
50. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears?
Imrie JE; Gardiner DS; Wilson A
Cytopathology; 2002 Apr; 13(2):133-4. PubMed ID: 11952754
[No Abstract] [Full Text] [Related]
51. The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer.
Yokoyama Y; Futagami M; Watanabe J; Sakuraba A; Nagasawa K; Maruyama H; Sato S
Hum Cell; 2016 Apr; 29(2):83-90. PubMed ID: 26739336
[TBL] [Abstract][Full Text] [Related]
52. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? Authors' reply.
Herbert A; Johnson J
Cytopathology; 2002 Apr; 13(2):133. PubMed ID: 11952753
[No Abstract] [Full Text] [Related]
53. Commentary: Liquid automation refreshes Dr Papanicolaou.
Watts G
BMJ; 2007 Jul; 335(7609):35-6. PubMed ID: 17615223
[No Abstract] [Full Text] [Related]
54. Liquid-based cytology: is this the way forward for cervical screening?
Moseley RP; Paget S
Cytopathology; 2002 Apr; 13(2):71-82. PubMed ID: 11952745
[TBL] [Abstract][Full Text] [Related]
55. Assessment of specimen adequacy reproducibility: an Italian experience.
Montanari G; Confortini M; Bellomi A; Cocchi V; Dalla Palma P; D'Ambrosio E; Giovagnoli MR; Navone R; Ronco G;
Diagn Cytopathol; 2003 Apr; 28(4):224-6. PubMed ID: 12672101
[TBL] [Abstract][Full Text] [Related]
56. Cellularity of liquid-based, thin-layer cervical cytology.
Zardawi IM
Acta Cytol; 2003; 47(5):943. PubMed ID: 14526685
[No Abstract] [Full Text] [Related]
57. Routine cervical cytology has no role after primary chemoradiation for cervical cancer.
Singh N; Titmuss E; Taylor A; Powell ME
Cytopathology; 2005 Dec; 16(6):315-6. PubMed ID: 16303047
[No Abstract] [Full Text] [Related]
58. How should adequacy of liquid-based cytology be defined?
Desai M; Herbert A
Cytopathology; 2006 Aug; 17(4):165-7. PubMed ID: 16879262
[No Abstract] [Full Text] [Related]
59. Liquid-based versus conventional cervical cytology.
Boon ME
Lancet; 2006 May; 367(9521):1482; author reply 1482-3. PubMed ID: 16679153
[No Abstract] [Full Text] [Related]
60. Liquid based cytology in cervical cancer screening.
Denton KJ
BMJ; 2007 Jul; 335(7609):1-2. PubMed ID: 17615183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
